Search:
MS Topics
Diagnosis Classification
Management of MS
Disease Modifying Agents
Imaging in MS
Clinical Trials in MS
Expert Exchange
Calendar of Events
Faculty
MSLeaders Home
Practice Profiles
Pharmacist Center
Nurse Center
Register for Updates
Understanding MS
 
Cost-Effective Management of Multiple Sclerosis (MS)
Sponsored by the Postgraduate Institute for Medicine
Release date: November 2004
Expiration date: November 2005
Estimated time to complete activity: 1 hour
This educational program is supported through an educational grant from Biogen Idec.
  • Program Overview
  • This educational activity presents experts in the field discussing the challenges of cost-effective management of patients with multiple sclerosis.
  • Goal Statement
  • Discuss and better understand the challenges of cost-effective management of patients
    with MS.
  • Target Audience
  • This activity has been designed to meet the educational needs of pharmacists involved in the management of patients with MS.
  • Learning Objectives
  • Upon completion of this activity, participants should be better able to:

    • Review the epidemiology of multiple sclerosis
    • Describe the total costs of care for MS patients
    • Discuss the role of disease-modifying therapies in the management of patients
      with MS
    • Discuss difficulties specific to managed care that are associated with assessment of cost-effectiveness of disease-modifying therapies in MS
  • Faculty: Multiple Sclerosis Expert Panel
  • Howard S. Rossman, DO
    Program Chair
    Medical Director, MS Center
    Michigan Institute for Neurological Disorders

    Dr. Rossman is founder and Medical Director of the M.I.N.D. Multiple Sclerosis Center, located in Farmington Hills, MI, presently servicing over 1800 patients with MS. Dr. Rossman earned his medical education at the Michigan State University College of Osteopathic Medicine, graduating in 1974 and attained his board certification in Neurology in 1981. On staff at numerous hospitals in the Detroit Metropolitan area, Dr. Rossman has been Chairman of Neurology at Botsford General Hospital since 1989. Dr. Rossman has been actively affiliated with Michigan State University, attaining the rank of Clinical Professor in Neurology in 1997, as well as directing the residency training program in Neurology at Botsford from 1983 to 2002. He has received numerous awards and citations for excellence in teaching, as well as being awarded the honor of Michigan State University College of Osteopathic Medicine Alumnus of the Year in 1984.

    Debra J. Stern, RPh
    Vice President, Rxperts

    Debbie Stern, RPh, is currently vice president of Rxperts, a managed care consulting firm, where she is responsible for designing and implementing comprehensive programs to meet the needs of managed care clients. Debbie is a nationally recognized speaker, meeting facilitator and consultant for a wide variety of clients, including the pharmaceutical industry, health plans, pharmacy benefit management (PBM) companies, specialty pharmacy companies and technology companies. Debbie has recently devoted considerable time to projects related to specialty pharmacy for all segments of the health care industry.

    Previously, Debbie was the director of pharmacy services at Prescription Solutions, a PBM company in Costa Mesa, California. Debbie was responsible for managing all aspects of pharmacy benefits for her clients, including operations, clinical services, outcomes management, budgeting and forecasting and personnel management. Prior to joining Prescription Solutions, Debbie was involved in the start-up operations of Preferred Solutions, a PBM in San Jose, California. As the first pharmacist at Preferred Solutions, Debbie was responsible for setting up the clinical, client services, claims administration, contracting and finance departments.

    In addition to her managed care experience, Debbie spent five years in the pharmaceutical industry and ten years in retail pharmacy. She has a BS in pharmacy from the University of Cincinnati and is actively involved in the Academy of Managed Care Pharmacy, where she has recently completed a two-year term on the board of directors.

    Sheldon J. Rich, RPh, PhD
    President
    SJR Associates, LLC

    Sheldon J. Rich, RPh, PhD, is president of SJR Associates, LLC a healthcare consulting company located in West Bloomfield, Michigan. Dr. Rich has over 20 years experience in the pharmacy field, having practiced in hospital, retail and managed care pharmacy. He is a nationally recognized lecturer and moderator and provides consulting services to managed care organizations, physician practice groups, employers and pharmaceutical manufacturers.

    Prior to starting his own consulting practice, Dr. Rich was the director of pharmacy programs at SelectCare in Troy, Michigan, having served in that position for over six years. As the first pharmacy director employed by SelectCare, he developed a nationally recognized, cost-effective pharmacy program and pharmacy network. He was responsible for development of drug utilization review programs, served as the chairperson of the pharmacy and therapeutics committee and developed a comprehensive drug formulary. Dr. Rich also negotiated contracts with pharmaceutical manufacturers, pharmacy benefit managers and claims processors. He also instituted a pharmacy shared risk program with physician groups.

    Dr. Rich earned his pharmacy degree from the University of Michigan. He also holds a doctorate in theocentric business ethics. Dr. Rich has held the position of clinical assistant professor at the University of Michigan since 1982 and has held a dual appointment as an adjunct assistant professor with the College of Pharmacy and Allied Health Professions at Wayne State University since 1994. Having presented over 700 lectures locally, nationally and internationally, Dr. Rich is in demand as an expert speaker on the topics of managed care pharmacy practice, cholesterol management, asthma management, depression management, diabetes management and appropriate methods for controlling pharmacy costs. He has moderated over 100 meetings and advisory boards and has published numerous journal articles and has contributed to two textbooks. He also served eight years on the Michigan Board of Pharmacy, including three years as chairperson. Dr. Rich has received numerous professional awards and honors and is a member of numerous professional organizations.

  • Instructions for Credit
  • Pharmacist Continuing Education
    Accreditation Statement
    The Postgraduate Institute for Medicine is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

    Credit Designation
    The Postgraduate Institute for Medicine designates this continuing education activity for 1.0 contact hours (0.10 CEUs) of the Accreditation Council for Pharmacy Education. (Universal Program Number - 809-999-04-079-HO1)

  • Faculty Disclosure Statements
  • The Postgraduate Institute for Medicine has a conflict of interest policy that requires course faculty to disclose any real or apparent commercial financial affiliations related to the content of their presentations/materials. It is not assumed that these financial interests or affiliations will have an adverse impact on faculty presentations; they are simply noted here to fully inform participants.

    Howard S. Rossman, DO, FACN
    Grants/Research Support: Biogen Idec, Teva Neuroscience, Serono, Merck, Aventis, Genentech
    Consultant: Biogen Idec
    Speakers' Bureau: Biogen Idec, Teva, Serono

    Debbie Stern, RPh
    Consultant: Biogen Idec, Elan, Serono

    Sheldon J. Rich, RPh, PhD
    Consultant: Biogen Idec
    Speakers' Bureau: Berlex, Biogen Idec

  • Method of Participation
  • There are no fees for participating and receiving CE credit for this activity. During the period November 2004 through November 2005 participants must 1) read the learning objectives and faculty disclosures; 2) study the educational activity; 3) complete the post-test by recording the best answer to each question in the answer key on the evaluation form; 4) complete the evaluation form; and 5) mail or fax the evaluation form with answer key to the Postgraduate Institute for Medicine.

    A statement of credit will be issued only upon receipt of a completed activity evaluation form and a completed post-test with a score of 70% or better. Your statement of credit will be mailed to you within three weeks.

  • Media
  • Internet
  • Disclosure of Unlabeled Use
  • This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by FDA. The Postgraduate Institute for Medicine, Healthology, and Biogen Idec (Biogen) do not recommend the use of any agent outside of the labeled indications.

    The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the Postgraduate Institute for Medicine, Healthology, and Biogen. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications and warnings.

  • Disclaimer
  • Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient's conditions and possible contraindications on dangers in use, review of any applicable manufacturer's product information, and comparison with recommendations of other authorities.

    Produced by Healthology © 2004

  • Launch Presentation

  • Launch Multimedia Format

  • Launch Text Format

  • Search: